Cagrilintide + Samaglutide
From CAD $113 CAD $230
Form: Powder
Purity: 99.3%
TESTED FOR:
- PURITY
- STERILITY
- WEIGHT
- ENDOTOXINS(LPS)
Free Reconstitution solution automatically added to your cart with each order of vial.
This product is Made, Tested & Shipped From Canada.
Ships Today
Order by 1:00 PM EST
Free Shipping
For 2 or more vials
99%+ Purity Guaranteed
COA Verified+
Trackable Shipping
Cagrilintide + Semaglutide
Cagrilintide + Semaglutide is a dual-peptide research combination evaluated for interactions between complementary pathways regulating body weight, satiety, and glucose metabolism. Semaglutide is a selective GLP-1 receptor agonist, while Cagrilintide is an amylin analog targeting amylin receptor complexes in appetite-regulatory centers of the CNS. Studies investigate whether co-administration provides enhanced control of energy intake and metabolic balance compared to either agent alone.
Research models emphasize reduction of caloric consumption, improved glycemic parameters, and potential synergistic reductions in body weight through both satiety enhancement and gastric transit modulation.
Overview
Combined treatment paradigms examine effects on visceral adiposity, insulin sensitivity, and cardiometabolic indicators including lipids, inflammatory markers, and liver-related metabolic outcomes. The peptide pairing is further assessed for durability of weight change, adherence to controlled nutritional intake, and translation of CNS signaling modulation to whole-body metabolic stability.
Chemical Makeup
This product contains two synthetic peptide hormones with distinct receptor targets. Due to dual-component structure and manufacturing variability, a single definitive molecular formula is not listed. Analytical identity and purity are batch-verified.
- Observed Mass (MS): 711.9 Da
- Purity (HPLC): 99.42%
- Batch Number: 2025007
- Primary Retention Time: 3.48 min
- Instrument: LCMS-7800 Series (Calibrated)
- Analytical Note: Primary peak confirmed by mass and retention time; trace secondary peak area 0.58%
Research and Clinical Studies
Combination Therapy and Weight Management
Studies indicate greater weight reduction from co-administration compared to either GLP-1 or amylin analogs alone in controlled metabolic settings.
Glycemic Stability and Insulin Sensitivity
Evaluations in type 2 diabetes assess improvement in HbA1c, fasting plasma glucose, and post-meal glucose responses.
Visceral Adiposity and Lipid Profiles
Research monitors changes in abdominal fat burden, triglycerides, and markers of fatty acid metabolism.
Appetite Regulation and Meal Size
Preclinical and early-phase clinical research examines enhanced satiety signaling and decreased caloric intake relative to monotherapy.
Cardiometabolic Risk Factors
Investigations track blood pressure changes, oxidative balance, and reductions in markers associated with metabolic stress.
This investigational peptide combination is intended exclusively for scientific laboratory research by qualified personnel. Not for human or veterinary administration.
References
- Friedrichsen M, et al. Dual amylin and GLP-1 receptor agonism for obesity research. Lancet. 2021;398(10295):2164–2176. PMID: 34895744.
https://pubmed.ncbi.nlm.nih.gov/34895744/
- Lau J, et al. Extended-action amylin analog and metabolic outcomes. Nature. 2021;597:1–6. PMID: 34497389.
https://pubmed.ncbi.nlm.nih.gov/34497389/
- Kushner RF, et al. Semaglutide for weight management: a controlled evaluation. N Engl J Med. 2021;384(11):989–1002. PMID: 33567185.
https://pubmed.ncbi.nlm.nih.gov/33567185/
- Müller TD, et al. Gut-brain peptide combination therapies in obesity. Physiol Rev. 2022;102(4):1889–1963. PMID: 35426549.
https://pubmed.ncbi.nlm.nih.gov/35426549/
- Arora T, et al. Amylin receptor signaling in feeding behavior regulation. Am J Physiol Gastrointest Liver Physiol. 2019;317(3):G429–G438. PMID: 31226682.
https://pubmed.ncbi.nlm.nih.gov/31226682/
- Dicker D, et al. Synergistic metabolic impacts of combination incretin-based agents. Diabetes Obes Metab. 2023;25(4):897–908. PMID: 36352316.
https://pubmed.ncbi.nlm.nih.gov/36352316/
- ClinicalTrials.gov Identifier: NCT04871225. Combined incretin and amylin analog therapy in obesity research.
https://clinicaltrials.gov/ct2/show/NCT04871225
- ClinicalTrials.gov Identifier: NCT05051579. Dual pathway metabolic intervention in type 2 diabetes.
https://clinicaltrials.gov/ct2/show/NCT05051579
For Research Use Only. Not for human or veterinary use.
HIGHEST QUALITY PEPTIDES
Our products are scientifically formulated and manufactured in cGMP-compliant facilities.
FAST DELIVERY
Enjoy fast and reliable 3–5 day shipping.
Dedicated Customer Service
Our customer service team is highly knowledgeable in peptide research and its applications. We’re available 24/7 to assist you.
Tested. Verified. Trusted.
We take a laboratory-first approach to quality. Each batch is made under controlled conditions and verified by an independent lab (HPLC/MS). We only ship batches that test ≥99% purity, and we provide a full COA, including identity, methods, and chromatograms, for your review.
See the Process for Yourself
We make our peptides in our own cGMP lab. Watch the video to see how every vial is produced, tested, and handled with care.
Science Behind Our Peptides
A clear explanation of how our peptides work, their benefits, why quality matters for best results, and what you should know.
Categories
Categories
How do I know the peptides I order are exactly what the label says?
Every vial we sell comes from a lab that follows current Good Manufacturing Practices (cGMP). That means each step of production is documented and controlled. Before a batch is released, it’s tested by independent third-party labs for purity, identity, and sterility. Certificates of analysis are available so you can see the exact test results.
Are your peptides produced in a sterile and controlled environment?
Yes. The labs we work with use ISO-certified clean rooms where air quality, equipment, and handling procedures are tightly regulated. Staff are trained to pharmaceutical-grade standards. This ensures the peptides are produced in an environment that minimizes contamination risks.
What about shipping? Do the peptides remain stable in transit?
Peptides in lyophilized (freeze-dried) form are stable at room temperature for transport. Once you receive them, refrigeration is recommended to maintain long-term integrity. We package every order securely to prevent damage and ship promptly, so your vials arrive in optimal condition.
How do I know you actually make these peptides yourselves?
We operate under strict in-house protocols that follow current Good Manufacturing Practices (cGMP). That means our team oversees the entire process from sourcing raw amino acids to the final lyophilized vial. Nothing is outsourced or repackaged. This gives us full control over purity, consistency, and sterility, and it’s why we can stand behind every single vial we ship.
What should I do with the vials once they arrive?
Store them in the refrigerator, away from direct light and heat. If you need to keep them longer, some peptides can be stored frozen. Each vial comes with clear handling instructions so you know the proper conditions for stability.
What proof do you have that your peptides are legitimate?
The strongest proof is transparency. For every peptide, we can provide certificates of analysis, manufacturing documentation, and references to the published scientific research behind it. If you ever have questions, we’ll show you the data rather than ask you to take our word for it.